Emmanuel Macron’s high-stakes gamble - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
社评

Emmanuel Macron’s high-stakes gamble

Trying to contain the far right through early elections could badly backfire

It is time to end the “fever”. That was how France’s president Emmanuel Macron explained his stunning decision on Sunday to dissolve the National Assembly and call snap legislative polls after the far right won a crushing victory in European parliamentary elections. His pro-EU centrist alliance limped in to a distant second place.

Before this weekend, France’s reckoning with the far right was scheduled for 2027 when Macron steps down. The campaign of Marine Le Pen, leader of the Rassemblement National, to succeed him as president was looking increasingly unstoppable — but still years away. Now that reckoning, with grave implications for France’s democracy and the future of Europe, will come in less than a month.

Macron’s snap election is an extraordinarily risky gamble. His intention appears to be to shake French voters out of their feverish delusions about what the far right would be like in power. The choice between France’s mainstream parties and a nationalist, Eurosceptic, anti-immigrant group whose policies would plunge the country into conflict with the EU ought to be an obvious one. The French may indeed balk at installing an RN government. But too many are bitterly disillusioned with the other parties and contemptuous of Macron for comfort.

A second line of defence is to persuade the other parties to strike electoral pacts to maximise the chances of defeating RN candidates. But Macron has left precious little time for party leaders to thrash out a deal. The president has repeatedly invoked the need to uphold the cordon sanitaire against the far right at all costs, while sometimes neglecting it himself, as in the last parliamentary elections in 2022. He has also done much to demolish France’s traditional centrist parties, although they also have themselves to blame for their fading popularity. They are, understandably, deeply sceptical of his “après moi le déluge” approach.

An unspoken part of Macron’s gamble is the prophylactic effect: if it ends up administering a mild dose of RN in government now, perhaps without an absolute majority, the hope is that it may inoculate French voters against a much more serious dose later, in the shape of Le Pen in the presidency.

As president, Macron could use his position to call out the excesses of an RN-led government. But what if such a government, with Le Pen’s 28-year-old protégé Jordan Bardella as premier, was to moderate in government, as the hard-right Giorgia Meloni has done in Italy? Populist parties elsewhere have been tamed, to a degree, once faced with responsibilities of power (and Donald Trump showed even a chaotic spell for a populist in power does not prevent voters from wanting more). France’s electorate might then be prepared to entrust Le Pen with the presidency in 2027, without the checks on power that exist in Rome. This makes the risks of the far right in power higher in France than in other European countries.

Macron has few risk-free options at this stage. Waiting for the clock to tick down on his presidency, while his centrist government lacks a parliamentary majority, would turn him quickly into a lame duck. There is no succession plan. Whoever wants to replace him, from the political centre, will have to rebuild a winning electoral coalition. Nonetheless, precipitating a fresh vote is still a hazardous venture.

The cordon sanitaire is being stretched across Europe, as Sunday’s elections showed. Some nine EU governments have, or will soon have, the hard right inside or in support. France could be the tenth. With war raging in Europe, competitiveness declining and the urgent need to step up the green transition, the EU needs a France that is fully engaged. If Macron’s wager backfires, it may soon have the opposite.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英国生物技术公司新药降低量身定制式癌症疗法副作用

Autolus用于治疗急性淋巴细胞白血病的新型Car-T细胞疗法在美国获批,该疗法与癌细胞结合所需时间更短,因此副作用更小。

前保守党财政大臣告诫工党现任勿看衰英国前景

杰里米•亨特表示,英国在关键增长领域表现强劲,应该停止贬低自己。

Lex专栏:游戏机制造商在低迷市场中表现强劲

虽然游戏机老化通常意味着游戏公司收入持续下降,但多年未推出新产品的索尼和任天堂等游戏公司仍表现强劲。

为年度展望报告辩护

巴克兰:定期回顾投资框架以及进行经济和市场展望是一项良好的做法。

企业长寿的奥秘为何对投资者很重要

长寿公司除了具有凝聚力、宽容度和财务保守等特征外,几乎没有什么共同点。
1天前

特朗普上台能否解决加拿大经济疲软问题?

经济学家表示,来自美国的冲击可能会使该国经济摆脱麻木状态。
设置字号×
最小
较小
默认
较大
最大
分享×